Mohamed B.
- Country
- France
- Department
- Digestive Oncology Department
Research Overview
- Multiparametric Dynamic Whole-Body 68Ga-PSMA PET Imaging for Recurrence Detection in Hepatocellular Carcinoma: HIMIKO Study
- Phase 1b Study of NP137 with Atezolizumab-Bevacizumab in First-Line Treatment of Unresectable Hepatocellular Carcinoma
- Evaluation of 89Zirconium-labelled Girentuximab PET-CT Imaging in Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Gastroenteropancreatic Neuroendocrine Neoplasms
Data & Insights
Has run more than one trial at 211 of 441 partner sites.
Specializations
Liver Cancer Expertise
Specializes in investigating innovative treatments for hepatocellular carcinoma (HCC) across various stages, with particular focus on intermediate and advanced cases. The investigator explores both curative treatment approaches and management strategies for unresectable disease.
- Transarterial chemoembolization (TACE) combinations
- Immunotherapy applications in HCC
- Post-transplant cancer management
Biliary Tract Cancer Research
Focuses on developing treatment strategies for advanced biliary tract cancers (BTC), including innovative approaches for cholangiocarcinoma. Investigates personalized medicine approaches and novel therapeutic combinations.
- First-line combination therapies
- Targeted molecular treatments
- Immunotherapy integration
Gastrointestinal Cancer Innovation
Leads research in gastrointestinal cancer treatment optimization, with emphasis on personalized approaches and novel therapeutic combinations. Specializes in developing strategies for patients with specific genetic profiles and enzyme deficiencies.
- Chemotherapy dose individualization
- Novel drug combinations
- Biomarker-driven treatments
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.